Alcohol use disorders and mortality in Nordic countries

shutterstock_69592525

Andrew Jones appraises a recent study of mortality and life expectancy of people with alcohol use disorders in Denmark, Finland and Sweden, which provides some useful insight into the impact of hazardous alcohol use.

[read the full story...]

CBT for insomnia in psychiatric populations: an effective alternative to hypnotics?

shutterstock_sheep asleep

Amy Green appraises a systematic review of CBT for insomnia (CBTi) in people with comorbid mental illness, which concludes that cognitive behaviour therapy could be an effective alternative to hypnotics. However, concerns about the review methodology cast some doubt on the findings.

[read the full story...]

Alcohol misuse and PTSD comorbidity: a significant problem lacking solutions

shutterstock_222051436

Current NICE guidelines state that PTSD should not be dealt with unless alcohol dependence is first treated. Paul Christiansen summarises a systematic review of the comorbidity between PTSD and alcohol misuse and wonders where the guidance leaves patients and professionals.

[read the full story...]

Acamprosate and oral naltrexone may improve consumption related outcomes for people with alcohol use disorders

shutterstock_141815629

A new systematic review suggests that, when used alongside psychosocial interventions, medication can result in better alcohol consumption outcomes for people with drinking problems.

[read the full story...]

Should we be prescribing medication to help people with alcohol use disorders?

shutterstock_128350532

Alcohol Use Disorders (AUDs) are common, chronic conditions which cause substantial harm to the individual and society. They are associated with substantial morbidity (Schuckit, 2009) and responsible for approximately 4% of all deaths annually. The approximate cost of AUDs to the National Health Service is upwards of £3 billion per year. Less than one-third of [read the full story...]

Targeted mindfulness-based relapse prevention may support long-term outcomes for substance use disorders

shutterstock_141036142

Approximately 10.6% of individuals with Substance Use Disorders (SUD) in the US seek treatment, with 40-60% relapsing within a year (Dept of Health and Human Services, 2008; McLellan et al, 2000). This highlights a real need for substance abuse treatment that focuses on relapse prevention. This blog summarises a recent RCT from JAMA Psychiatry on [read the full story...]

New evidence update from NICE on the prevention of problem drinking

shutterstock_140017105

The National Institute for Health and Care Excellence (NICE) has recently published an evidence update focussed on preventing harmful drinking. This update builds upon previous recommendations (NICE PH24, 2010) and is aimed at increasing awareness of the latest evidence available. Furthermore, the update indicates whether any new research may have potential impact on future NICE [read the full story...]

CBT and motivational interviewing are effective treatments for comorbid alcohol use disorders and depression, says new meta-analysis

shutterstock_93063772

Alcohol use disorder is frequently comorbid with major depressive disorder, and the disease burden associated with this dual diagnosis is considerably greater than that attributed to each disorder in isolation. This creates a problem for clinicians who are trying to treat depressed problem drinkers, because many services are set up to deal with only one [read the full story...]

Psychiatric illnesses and some chronic physical illnesses are associated with an increased risk of self-harm and suicide

shutterstock_110328875

Last month, the Department of Health published the ‘Closing the Gap’ report, which highlighted the importance of better integration of physical and mental health care at every level. The report specifically flagged up the need for frontline services to respond better to people who self-harm, and cited statistics that emphasise the cyclical nature of the [read the full story...]

Is gabapentin a promising drug for the treatment of alcohol dependence?

shutterstock_132024347

Alcohol misuse is responsible for about 4% of all deaths annually, and in the UK it costs the NHS more than £3 billion per year.  A number of medications are currently licensed for the treatment of alcohol dependence. Unfortunately the medications don’t work for everyone and in the USA at least, fewer than 10% of [read the full story...]